Outcomes of the transformation of follicular lymphoma to diffuse large B ‐cell lymphoma in the rituximab era: A population‐based study
ConclusionThe outcome of t-DLBCL in the rituximab era was better than historical series before the rituximab era. Due to the good prognosis, we did not recommend autologous stem cell transplantation for t-DLBCL receiving watch-and-wait or radiation as initial therapy before HT.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Wenshuai Zheng,
Mingjuan Liu,
Lixun Guan,
Shenyu Wang Tags: RESEARCH ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Epidemiology | History of Medicine | Lymphoma | Rituxan | Stem Cell Therapy | Stem Cells | Study | Transplants